Skip to main content
. 2023 Nov 29;136(24):2931–2937. doi: 10.1097/CM9.0000000000002939

Figure 4.

Figure 4

Change of BMD absolute value at baseline and 1 year after switching to TAF/FTC/BIC. BIC: Bictegravir sodium; BMD: Bone mineral density; FTC: Emtricitabine; TAF: Tenofovir alafenamide.